A dictation system for reporting prescribing errors in community pharmacies

International Journal of Pharmacy Practice

Volumn 12, Issue 1, 2004, Pages 13-19

  Kennedy, Amanda G ^a,b,c   Littenberg, Benjamin ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b Department of Medicine ^*  (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL ARTICLE; EVALUATION; FEMALE; HUMAN; MALE; MEDICATION ERROR; PHARMACY; PILOT STUDY; PRESCRIPTION; PRIORITY JOURNAL; UNITED STATES;

EID: 9344223984     PISSN: 09617671     EISSN: None     Source Type: Journal    
DOI: 10.1211/096176704773048704     Document Type: Article

References (20)

1. American Society of Health System Pharmacists. Suggested definitions and relationships among medication misadventures, medication errors, adverse drug events, and adverse drug reactions; 1998. Available at: http://www.ashp.org. Accessed July 24, 2002.
2. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: Updating the cost-of-illness model. J Am Pharm Assoc 2001;41:192-9.
3. Buurma H, de Smet PA, van den Hoff OP, Egberts AC. Nature, frequency and determinants of prescription modifications in Dutch community pharmacies. Br J Clin Pharmacol 2001;52:85-91.
4. Rupp MT, DeYoung M, Schondelmeyer SW. Prescribing problems and pharmacist interventions in community practice. Med Care 1992;30:926-40.
5. Hulls V, Emmerton L. Prescription interventions in New Zealand community pharmacy. J Soc Admin Pharm 1996;13:198-205.
6. Christensen DB, Neil N, Fassett WE, Smith DH, Holmes G, Stergachis A. Frequency and characteristics of cognitive services provided in response to a financial incentive. J Am Pharm Assoc 2000;40:609-17.
7. Rupp MT, Schondelmeyer SW, Wilson GT, Krause JE. Documenting prescribing errors and pharmacist interventions in community pharmacy practice. Am Pharm 1988;NS28:30-7.
8. Caleo S, Benrimoj S, Collins D, Lauchlan R, Stewart K. Clinical evaluation of community pharmacists' interventions. Int J Pharm Pract 1996;4:221-7.
9. Greene R. Survey of prescription anomalies in community pharmacies: Interventions and outcomes. Pharm J 1995;254:873-5.
10. Hawksworth GM, Corlett AJ, Wright DJ, Chrystyn H. Clinical pharmacy interventions by community pharmacists during the dispensing process. Br J Clin Pharmacol 1999;47:695-700.
11. Rupp MT. Value of community pharmacists' interventions to correct prescribing errors. Ann Pharmacother 1992;26:1580-4.
12. Dobie RL, Rascati KL. Documenting the value of pharmacist interventions. Am Pharm 1994;NS34:50-4.
13. Medication errors. Cohen MR, editor. Washington, DC: American Pharmaceutical Association; 1999.
14. United States Pharmacopeia. Available at: http://www.usp. org. Accessed November 17, 2003.
15. Kohn LT, Corrigan JM, Donaldson MS, editors. To err is human: Building a safer health system. Washington, DC: National Academy Press; 2000.
16. Davydov L, Caliendo GC, Smith LG, Mehl B. Analysis of clinical intervention documentation by dispensing pharmacists in a teaching hospital. Hosp Pharm 2003;38:346-50.
17. Reason J. Managing the risks of organizational accidents. Hampshire: Ashgate Publishing Ltd; 1997.
18. National Coordinating Council for Medication Error Reporting and Prevention. Use of medication error rates to compare health care organizations is of no value; 2002. Available at: http://www.nccmerp.org. Accessed November 17, 2003.
19. Kennedy AG, Littenberg B, Vezina LC. Vioxx-viagra confusion. Am J Health Syst Pharm 2002;59:2112.
20. Weinberger M, Murray MD, Marrero DG, Brewer N, Lykens M, Harris LE, et al. Issues in conducting randomized controlled trials of health services research interventions in nonacademic practice settings: The case of retail pharmacies. Health Serv Res 2002;37:1067-77.